Hurley Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.1K Hold
290
– – 0.03% 181
2026
Q2
$55.2K Sell
290
-51
-15% -$8.77K 0.03% 177
2026
Q1
$57.6K Hold
341
– – 0.03% 165
2025
Q4
$57.5K Hold
341
– – 0.03% 163
2025
Q3
$49.2K Buy
341
+1
+0.3% +$136 0.03% 196
2025
Q2
$43.1K Sell
340
-1
-0.3% -$123 0.03% 168
2025
Q1
$43.6K Sell
341
-99
-23% -$13.4K 0.03% 185
2024
Q4
$59K Buy
+440
New +$61.9K 0.05% 133

Other funds holding IBB

Hurley Capital's IBB Position: Q3 2026 in Review

Hurley Capital held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 290 shares worth $61.1K. The position accounts for 0.03% of the portfolio, ranked #181.

Hurley Capital first reported a position in IBB in Q4 2024 and has held it in 8 quarters since. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Hurley Capital held 290 shares of iShares Biotechnology ETF worth $61.1K as of Q3 2026.
  • Hurley Capital left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.03% of Hurley Capital's portfolio in Q3 2026, its #181 holding.
  • Hurley Capital first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 8 quarters since.
  • 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.